

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 71.51 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 92.18 | Oscillator | Sell |
| Williams %R (14) | -1.72 | Oscillator | Sell |
| MACD (12, 26, 9) | 11.32 (Hist 1.93) | Oscillator | Strong Buy |
| Average Directional Index (14) | 23.60 (+DI 38.3 / -DI 14.7) | Trend | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 19, 26 | Schlossman Robert | officer: Chief Legal Officer | A-Award | 14,185 | — |
FY2026 · 10-K disclosure
FY2019 · 10-K disclosure
| EMA 20 | 218.43 | MA | Strong Buy |
| SMA 20 | 216.17 | MA | Strong Buy |
| EMA 50 | 200.06 | MA | Strong Buy |
| SMA 50 | 197.19 | MA | Strong Buy |
| SMA 200 | 165.97 | MA | Strong Buy |
| Oct 19, 26 |
| Rubin Kevin |
| officer: Chief Financial Officer |
| A-Award |
| 19,859 |
| — |
| Oct 19, 26 | Geller Adam | officer: Chief Product Officer | A-Award | 19,859 | — |
| Oct 9, 26 | Geller Adam | officer: Chief Product Officer | M-Exempt | 23,958 @ $205.61 | $4.93M |
| Oct 9, 26 | Geller Adam | officer: Chief Product Officer | S-Sale | 21,875 @ $225.00 | $4.92M |
| Oct 12, 26 | Geller Adam | officer: Chief Product Officer | M-Exempt | 1,042 @ $205.61 | $214.2K |
| Oct 9, 26 | Geller Adam | officer: Chief Product Officer | S-Sale | 2,083 @ $230.00 | $479.1K |
| Oct 12, 26 | Geller Adam | officer: Chief Product Officer | S-Sale | 1,042 @ $235.95 | $245.9K |
Stock news · updated daily
On CNBC's “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, picked Zscaler, Inc. (NASDAQ:ZS).
In the most recent trading session, Zscaler (ZS) closed at $237.5, indicating a +2.67% shift from the previous trading day.
Zscaler, Inc. ZS is strengthening its data security business as companies adopt artificial intelligence (AI) and face growing risks of sensitive information leaks. Its integrated security platform could help enterprises simplify data protection while creating opportunities to win larger deals and expand existing customer relationships.
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zscaler, Inc. ("Zscaler" or the "Company") (NASDAQ: ZS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Zscaler, Inc. (NASDAQ:ZS) stock is trading higher by almost 7% on Wednesday after DA Davidson initiated coverage with a Neutral rating and announced price target of $215.
Wall Street analysts delivered a flurry of bold calls Wednesday, including a double-downgrade that shocked one cybersecurity giant and a sharp cut on a beloved restaurant chain. Find out which stocks got upgraded, buried, or newly covered before the market opens.
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zscaler, Inc. (“Zscaler” or the “Company”) (NASDAQ: ZS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
AI agents are creating a cybersecurity problem traditional defenses were not built to handle: software that can access sensitive data, call tools and take action without waiting for a human. Dan Ives believes that shift could reshape corporate technology budgets, pushing cybersecurity's share of IT spending from roughly 5% today to 10% over the next three years.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Sep 3, 2026 | 1.09 | 1.19 | Beat 9.2% | $898.2M |
| May 26, 2026 | 1.01 | 1.08 | Beat 6.9% | $850.5M |
| Feb 26, 2026 | 0.89 | 1.01 | Beat 13.0% | $815.8M |
| Nov 25, 2025 | 0.86 | 0.96 | Beat 12.1% | $788.1M |
| Sep 2, 2025 | 0.80 | 0.89 | Beat 11.2% | $719.2M |
| May 29, 2025 | 0.75 | 0.84 | Beat 11.7% | $678.0M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 20, 2026 | 2026-10-20 21:22:47 | View |
| 4 | Oct 20, 2026 | 2026-10-20 21:21:53 | View |
| 4 | Oct 20, 2026 | 2026-10-20 21:21:06 | View |
| 4 | Oct 13, 2026 | 2026-10-13 16:47:21 | View |
| 8-K | Oct 6, 2026 | 2026-10-06 06:02:03 | View |
| 4 | Sep 28, 2026 | 2026-09-28 20:20:22 | View |
| 8-K | Sep 24, 2026 | 2026-09-24 16:07:41 | View |
| 4 | Sep 21, 2026 | 2026-09-21 17:57:56 | View |
| 4 | Sep 21, 2026 | 2026-09-21 17:52:17 | View |
| 4 | Sep 17, 2026 | 2026-09-17 19:46:13 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | ZS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -652.3x | -415.0x · sector 44.2x | Discount |
| Forward P/E (FY27E) | 52.3x | EPS est. 4.88 | Discount |
| Price / Book | 15.7x | 24.9x | Discount |
| Price / Sales | 12.4x | 14.1x | In line |
| EV / EBITDA | 227.3x | 128.4x | Elevated |
| Return on equity | -2.8% | — | Weak |
| Gross margin | 76.8% | 77.4% | In line |
| Debt / Equity | 0.71 | 1.24 | Moderate |
| Piotroski / Altman Z | 4/9 | Z 4.81 | Safe zone |
Discounted cash flow model
Current price $255.15
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 22, 26 |
| Freedom Broker |
| maintain |
| Buy |
| Buy |
| Oct 15, 26 | Citigroup | maintain | Buy | Buy |
| Oct 9, 26 | Citizens | maintain | Market Outperform | Market Outperform |
| Oct 7, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 7, 26 | Macquarie | maintain | Outperform | Outperform |
| Oct 7, 26 | UBS | maintain | Buy | Buy |
| Oct 7, 26 | Truist Securities | maintain | Buy | Buy |
| Oct 7, 26 | Scotiabank | maintain | Sector Outperform | Sector Outperform |
| Oct 7, 26 | JP Morgan | maintain | Overweight | Overweight |